Research and Cure

A possible treatment for X-linked congenital NDI is moving closer to human study. NDI-5001 is now part of a registered Phase 1b trial, giving families a meaningful sign of progress while research continues.

For families living with X-linked NDI, the daily reality is relentless. Producing up to 20 liters of urine a day, managing constant thirst, planning every outing around water access — and doing all of it with no real treatment in sight. Just management. Just coping. That may be beginning to change.